These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 16423422)

  • 1. A peptide competing with VEGF165 binding on neuropilin-1 mediates targeting of a chlorin-type photosensitizer and potentiates its photodynamic activity in human endothelial cells.
    Tirand L; Frochot C; Vanderesse R; Thomas N; Trinquet E; Pinel S; Viriot ML; Guillemin F; Barberi-Heyob M
    J Control Release; 2006 Mar; 111(1-2):153-64. PubMed ID: 16423422
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antitumor effect of 5-aminolevulinic acid-mediated photodynamic therapy can be enhanced by the use of a low dose of photofrin in human tumor xenografts.
    Peng Q; Warloe T; Moan J; Godal A; Apricena F; Giercksky KE; Nesland JM
    Cancer Res; 2001 Aug; 61(15):5824-32. PubMed ID: 11479222
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-flt1 peptide, a vascular endothelial growth factor receptor 1-specific hexapeptide, inhibits tumor growth and metastasis.
    Bae DG; Kim TD; Li G; Yoon WH; Chae CB
    Clin Cancer Res; 2005 Apr; 11(7):2651-61. PubMed ID: 15814646
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Schedule-dependent interaction between Doxorubicin and mTHPC-mediated photodynamic therapy in murine hepatoma in vitro and in vivo.
    Kirveliene V; Grazeliene G; Dabkeviciene D; Micke I; Kirvelis D; Juodka B; Didziapetriene J
    Cancer Chemother Pharmacol; 2006 Jan; 57(1):65-72. PubMed ID: 16001168
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heparin affin regulatory peptide binds to vascular endothelial growth factor (VEGF) and inhibits VEGF-induced angiogenesis.
    Héroult M; Bernard-Pierrot I; Delbé J; Hamma-Kourbali Y; Katsoris P; Barritault D; Papadimitriou E; Plouet J; Courty J
    Oncogene; 2004 Mar; 23(9):1745-53. PubMed ID: 15001987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuropilin-1 suppresses tumorigenic properties in a human pancreatic adenocarcinoma cell line lacking neuropilin-1 coreceptors.
    Gray MJ; Wey JS; Belcheva A; McCarty MF; Trevino JG; Evans DB; Ellis LM; Gallick GE
    Cancer Res; 2005 May; 65(9):3664-70. PubMed ID: 15867361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. VEGF-subtype specific protection of SCC and HUVECs from radiation induced cell death.
    Brieger J; Schroeder P; Gosepath J; Mann WJ
    Int J Mol Med; 2005 Jan; 15(1):145-51. PubMed ID: 15583841
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative sensitivity of microvascular endothelial cells, fibroblasts and tumor cells after in vitro photodynamic therapy with meso-tetra-hydroxyphenyl-chlorin.
    Triesscheijn M; Ruevekamp M; Aalders M; Baas P; Stewart FA
    Photochem Photobiol; 2004; 80(2):236-41. PubMed ID: 15362947
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Foscan-based photodynamic treatment in vivo: correlation between efficacy and Foscan accumulation in tumor, plasma and leukocytes.
    Maugain E; Sasnouski S; Zorin V; Merlin JL; Guillemin F; Bezdetnaya L
    Oncol Rep; 2004 Sep; 12(3):639-45. PubMed ID: 15289849
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of vascular endothelial growth factor receptors in melanocytes.
    Kim EJ; Park HY; Yaar M; Gilchrest BA
    Exp Dermatol; 2005 Aug; 14(8):625-33. PubMed ID: 16026585
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of intensive tumor suppression by antiangiogenic photodynamic therapy using polycation-modified liposomal photosensitizer.
    Takeuchi Y; Kurohane K; Ichikawa K; Yonezawa S; Nango M; Oku N
    Cancer; 2003 Apr; 97(8):2027-34. PubMed ID: 12673734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A study of the stability of tri(glucosyloxyphenyl)chlorin, a sensitizer for photodynamic therapy, in human colon tumoural cells: a liquid chromatography and MALDI-TOF mass spectrometry analysis.
    Laville I; Pigaglio S; Blais JC; Loock B; Maillard P; Grierson DS; Blais J
    Bioorg Med Chem; 2004 Jul; 12(13):3673-82. PubMed ID: 15186852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design, synthesis, and biological evaluation of folic acid targeted tetraphenylporphyrin as novel photosensitizers for selective photodynamic therapy.
    Schneider R; Schmitt F; Frochot C; Fort Y; Lourette N; Guillemin F; Müller JF; Barberi-Heyob M
    Bioorg Med Chem; 2005 Apr; 13(8):2799-808. PubMed ID: 15781391
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of photodynamic therapy using a fractionated dosing of mono-L-aspartyl chlorin e6 in a murine tumor.
    Webber J; Leeson B; Fromm D; Kessel D
    J Photochem Photobiol B; 2005 Feb; 78(2):135-40. PubMed ID: 15664500
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of Hypocrellin B in a human bladder tumor model in experimental photodynamic therapy: biodistribution, light dose and drug-light interval effects.
    Chin W; Lau W; Cheng C; Olivo M
    Int J Oncol; 2004 Sep; 25(3):623-9. PubMed ID: 15289863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of VEGF receptors in cocultured neuroblastoma cells.
    Beierle EA; Dai W; Langham MR; Copeland EM; Chen MK
    J Surg Res; 2004 Jun; 119(1):56-65. PubMed ID: 15126083
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of photodynamic therapy-induced early apoptosis in human salivary gland tumor cells in vitro and in a mouse tumor model.
    Kaneko T; Chiba H; Yasuda T; Kusama K
    Oral Oncol; 2004 Sep; 40(8):787-92. PubMed ID: 15288832
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Continuous delivery of endogenous inhibitors from poly(lactic-co-glycolic acid) polymeric microspheres inhibits glioma tumor growth.
    Benny O; Duvshani-Eshet M; Cargioli T; Bello L; Bikfalvi A; Carroll RS; Machluf M
    Clin Cancer Res; 2005 Jan; 11(2 Pt 1):768-76. PubMed ID: 15701867
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeted inhibition of p38alpha MAPK suppresses tumor-associated endothelial cell migration in response to hypericin-based photodynamic therapy.
    Hendrickx N; Dewaele M; Buytaert E; Marsboom G; Janssens S; Van Boven M; Vandenheede JR; de Witte P; Agostinis P
    Biochem Biophys Res Commun; 2005 Nov; 337(3):928-35. PubMed ID: 16214108
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcome of mTHPC mediated photodynamic therapy is primarily determined by the vascular response.
    Triesscheijn M; Ruevekamp M; Aalders M; Baas P; Stewart FA
    Photochem Photobiol; 2005; 81(5):1161-7. PubMed ID: 15934792
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.